Immunocore Holdings IMCR
NASDAQ IMCR
$36.20 -1.37 (-3.65%)
As of: Sep 4, 2026 · 3:19 PM EDT

Immunocore Holdings (IMCR) Gross Margin (QoQ) (2021 - 2026)

Analysis

Immunocore Holdings (IMCR) Gross Margin (QoQ) (2021 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.43 Bn 130.58 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.34 Bn 58.15 Bn 1.37 Bn
4 Moderna 57.98 Bn 52.85 Bn 52.00 Mn
5 Revolution Medicines 43.98 Bn 43.98 Bn -
6 BeOne Medicines 39.92 Bn 34.82 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.42 Bn 32.11 Bn 992.69 Mn
8 Royalty Pharma 28.42 Bn 27.58 Bn -
9 Insmed 27.36 Bn 26.20 Bn 358.27 Mn
10 Immunocore Holdings 1.84 Bn 961.46 Mn 114.84 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -53.00
Mar 31, 2026 218.00
Dec 31, 2025 -209.00
Sep 30, 2025 57.00
Jun 30, 2025 -18.00
Mar 31, 2025 -49.00
Dec 31, 2024 17.00
Sep 30, 2024 171.00
Jun 30, 2024 -191.00
Mar 31, 2024 -6.00
Dec 31, 2023 14.00
Sep 30, 2023 141.00
Jun 30, 2023 -144.00
Mar 31, 2023 -17.00
Dec 31, 2022 -7.00
Sep 30, 2022 62.00
Dec 31, 2021 0.00